AustralianSuper Pty Ltd trimmed its holdings in shares of The Procter & Gamble Company (NYSE:PG - Free Report) by 19.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,480,730 shares of the company's stock after selling 346,435 shares during the period. Procter & Gamble comprises about 1.2% of AustralianSuper Pty Ltd's portfolio, making the stock its 12th largest position. AustralianSuper Pty Ltd owned approximately 0.06% of Procter & Gamble worth $248,244,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Concurrent Investment Advisors LLC raised its position in shares of Procter & Gamble by 4.5% in the 3rd quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company's stock valued at $16,300,000 after purchasing an additional 4,035 shares during the last quarter. Copley Financial Group Inc. purchased a new position in shares of Procter & Gamble in the 3rd quarter valued at approximately $668,000. Fortem Financial Group LLC purchased a new position in shares of Procter & Gamble in the 4th quarter valued at approximately $569,000. Richard C. Young & CO. LTD. raised its position in shares of Procter & Gamble by 2.1% in the 4th quarter. Richard C. Young & CO. LTD. now owns 123,853 shares of the company's stock valued at $20,764,000 after purchasing an additional 2,568 shares during the last quarter. Finally, Nordea Investment Management AB increased its holdings in Procter & Gamble by 7.5% in the 4th quarter. Nordea Investment Management AB now owns 2,898,569 shares of the company's stock worth $484,583,000 after buying an additional 201,695 shares during the period. 65.77% of the stock is currently owned by institutional investors.
Procter & Gamble Stock Performance
Shares of Procter & Gamble stock traded down $8.18 during trading hours on Friday, hitting $162.84. 13,171,287 shares of the company were exchanged, compared to its average volume of 7,257,899. The Procter & Gamble Company has a 1 year low of $153.52 and a 1 year high of $180.43. The company has a current ratio of 0.76, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The business has a 50-day moving average of $166.73 and a 200-day moving average of $169.45. The stock has a market capitalization of $381.85 billion, a price-to-earnings ratio of 25.93, a P/E/G ratio of 3.79 and a beta of 0.45.
Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings results on Wednesday, January 22nd. The company reported $1.88 EPS for the quarter, topping the consensus estimate of $1.86 by $0.02. Procter & Gamble had a return on equity of 33.00% and a net margin of 18.35%. The business had revenue of $21.88 billion during the quarter, compared to analysts' expectations of $21.66 billion. During the same quarter in the prior year, the business earned $1.84 earnings per share. The company's quarterly revenue was up 2.1% compared to the same quarter last year. As a group, analysts expect that The Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Procter & Gamble Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 18th. Investors of record on Friday, January 24th will be issued a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a yield of 2.47%. The ex-dividend date is Friday, January 24th. Procter & Gamble's dividend payout ratio is presently 64.01%.
Analyst Upgrades and Downgrades
PG has been the topic of several research reports. Barclays increased their price target on shares of Procter & Gamble from $155.00 to $159.00 and gave the stock an "equal weight" rating in a report on Thursday, January 23rd. Stifel Nicolaus raised their price objective on shares of Procter & Gamble from $161.00 to $165.00 and gave the stock a "hold" rating in a research note on Thursday, January 23rd. Morgan Stanley raised their price objective on shares of Procter & Gamble from $174.00 to $191.00 and gave the stock an "overweight" rating in a research note on Monday, October 21st. Evercore ISI raised their price objective on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an "outperform" rating in a research note on Monday, October 21st. Finally, DA Davidson reaffirmed a "buy" rating and set a $209.00 price objective on shares of Procter & Gamble in a research note on Thursday, January 23rd. Eight investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $180.53.
View Our Latest Analysis on PG
Insider Buying and Selling
In related news, insider Marc S. Pritchard sold 90,450 shares of Procter & Gamble stock in a transaction dated Thursday, January 23rd. The stock was sold at an average price of $163.84, for a total transaction of $14,819,328.00. Following the completion of the sale, the insider now owns 172,814 shares in the company, valued at approximately $28,313,845.76. This trade represents a 34.36 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Gary A. Coombe sold 47,847 shares of Procter & Gamble stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total value of $8,604,804.48. Following the sale, the chief executive officer now owns 39,977 shares of the company's stock, valued at approximately $7,189,463.68. This represents a 54.48 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 151,097 shares of company stock valued at $25,635,076 over the last quarter. Company insiders own 0.18% of the company's stock.
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
